| 31 |
Analysis of CD22 cis-ligands using a synthetic sialoside binding to CD22 with ultra-high affinity |
Department of Pharmaceutical Organic Chemistry |
2025 |
| 32 |
Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article |
Department of Medicinal Chemistry |
2025 |
| 33 |
Antiparasitic efficacy of geraniol from Apiaceae family in scabies treatment |
Department of Pharmacognosy |
2025 |
| 34 |
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances |
Department of Medicinal Chemistry |
2025 |
| 35 |
CD34+CD38-stem cells and CD34+CD38+progenitor cells as markers of chemotherapy response in acute myeloid leukemia patients |
Department of Microbiology and Immunology |
2025 |
| 36 |
CDK2 Inhibitors: Rationally Directed Discovery of a Novel Potent Lead derived from Cyclohepta[e]thieno[2,3-b]pyridine |
Department of Pharmaceutical Organic Chemistry |
2025 |
| 37 |
Clinical significance of interleukin 10, interleukin 33, and interleukin 35 on induction chemotherapy in acute myeloid leukemia patients |
Department of Microbiology and Immunology |
2025 |
| 38 |
Cobalt-induced oxidative stress and defense responses of Adhatoda vasica proliferated shoots |
Department of Pharmacognosy |
2025 |
| 39 |
Comparative study of different treatment modalities for melasma: introducing a novel nanotechnology-based tranexamic acid microemulsion |
Department of Industrial Pharmacy |
2025 |
| 40 |
Copper-chelation-induced ratiometric fluorescence response for sensitive ratiometric detection of zoledronic acid: implications for monitoring in renal impairment |
Department of Pharmaceutical Analytical Chemistry |
2025 |